| Editor's Choice: Prevention & Risk Reduction | Researchers used ultrasound imaging to examine the hearts of young adults who smoked marijuana and those who did not. Their full analysis was published in the Journal of Applied Physiology Researchers used ultrasound imaging to examine the hearts of young adults who smoked marijuana and those who did not. Their full analysis was published in the Journal of Applied Physiology | | |
| The Mediterranean diet typically prioritizes eating fruits and vegetables and limiting fatty foods and animal products. The Mediterranean diet typically prioritizes eating fruits and vegetables and limiting fatty foods and animal products. | | |
| Chronic coronary syndromes can more than triple a person's chances of developing diabetes, researchers found. Chronic coronary syndromes can more than triple a person's chances of developing diabetes, researchers found. | | |
| Rita Rastogi Kalyani, MD, an endocrinologist and associate professor at Johns Hopkins Medicine, shared her perspective on this crucial topic. Rita Rastogi Kalyani, MD, an endocrinologist and associate professor at Johns Hopkins Medicine, shared her perspective on this crucial topic. | | |
| The team sees significant potential in its findings, though they still hope to make the technique "simpler and more clinically implementable." The team sees significant potential in its findings, though they still hope to make the technique "simpler and more clinically implementable." | | |
| Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients. Researchers reviewed data from 34 different studies, covering a total of more than 63,000 patients. | | |
| After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance. After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance. | | |
| The findings, published in JAMA Cardiology, confirm that dapagliflozin is a safe, effective treatment option for patients with heart failure with reduced ejection fraction. The findings, published in JAMA Cardiology, confirm that dapagliflozin is a safe, effective treatment option for patients with heart failure with reduced ejection fraction. | | |
| The study's authors tracked the health of more than 134,000 individuals from 21 countries for nearly a decade. The study's authors tracked the health of more than 134,000 individuals from 21 countries for nearly a decade. | | |
| The authors tracked outcomes from more than 386,000 patients treated from 2001 to 2018, sharing their findings in Hypertension. The authors tracked outcomes from more than 386,000 patients treated from 2001 to 2018, sharing their findings in Hypertension. | | |
| |
|
| ![]() | |
|
